Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

NCT00436930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: autologous tumor cell vaccine
BIOLOGICAL: sargramostim
BIOLOGICAL: therapeutic autologous dendritic cells

Sponsor

Hoag Memorial Hospital Presbyterian